Iceland screens 80,000 for hidden cancer risk

NCT ID NCT03327597

First seen Sep 30, 2025 · Last updated May 14, 2026 · Updated 24 times

Summary

This study looks at whether screening healthy people for a condition called MGUS can help find multiple myeloma earlier and improve survival. Over 80,000 adults in Iceland were invited to participate. The goal is to see if early detection leads to better outcomes and fewer complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Iceland

    Reykjavik, Iceland

Conditions

Explore the condition pages connected to this study.